BodenheimerT., “Uneasy Alliance – Clinical Investigators and the Pharmaceutical Industry,”N. Engl. J. Med.342, no. 20 (2000): 1539–1544; WarnerT. D.GluckJ. P., “What do we Really Know about Conflicts of Interest in Biomedical Research?”Psychopharmacology (Berl)171, no.1 (2003): 36–46; BekelmanJ. E.LiY.GrossC. P., “Scope and Impact of Financial Conflicts of Interest in Biomedical Research,”JAMA289 (2003): 454–465; MosesH.DorseyE.MathesonD.TheirS., “Financial Anatomy of Biomedical Research,”JAMA294 (2005): 1333–1342.
2.
BoydE. A.BeroL. A., “Assessing Faculty Financial Relationships with Industry: A Case Study,”JAMA284 (2000): 2209–2214; BlumenthalD., “Participation of Life-Science Faculty in Research Relationships with Industry,”N. Engl. J. Med.335 (1996): 1734–1739; KrimskyS., “Financial Interests of Authors in Scientific Journals: A Pilot Study of 14 Publications,”Science and Engineering Ethics2, no. 4 (1996): 395–410.
3.
See Warner and Gluck, supra note 1.
4.
DjulbegovicB., “The Uncertainty Principle and Industry-Sponsored Research,”Lancet356, no. 9230 (2000): 635–638; KjaergardL. L. and Als-NielsenB., “Association between Competing Interests and Authors's Conclusions: Epidemiological Study of Randomized Clinical Trials Published in the BMJ,”British Medical Journal325, no. 7358 (2002): 249; BarnesD. E. and BeroL. A., “Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions,”JAMA279 (1998): 1566–1570; FriedmanL. S.RichterE. D., “Relationship between Conflicts of Interest and Research Results,”Journal of General Internal Medicine19, no. 1 (2004): 51–56.
5.
AndrewsL., “Money is Putting People at Risk in Biomedical Research,”Chronicle of Higher Education46, no. 27 (2000): B1, B4–5.
6.
SmithR., “Beyond Conflict of Interest: Transparency is the Key,”British Medical Journal317 (7154) (1998): 291–292; Association of American Medical Colleges (AAMC), Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution's Financial Interests in Human Research (Washington, DC: AAMC, 2002); ResnikD., Disclosing Conflicts of Interest to Research Subjects: An Ethical and Legal Analysis,”Accountability in Research11 (2004): 141–159.
7.
ThomsponD., “Understanding Financial Conflicts of Interest,”N. Engl. J. Med.329 (1993): 573–576.
8.
KrimskyS.RothenbergL. S., “Financial Interest and its Disclosure in Scientific Publications,”JAMA280, no. 3 (1998): 225–226; BrodyB.AndersonC.Van McCraryS.McCulloughL.MorganR.WrayN., “Expanding Disclosure of Conflicts of Interest: The Views of Stakeholders,”IRB Ethics and Human Research25, no.1 (2003): 1–8.
9.
McCraryS. V.AndersonC. B.JakovljevicB. S.KhanT.McCulloughL.WrayN.BrodyB., “A National Survey of Policies on Disclosure of Conflicts of Interests in Biomedical Research,”N. Engl. J. Med.342 (2000): 1621–1626; DHHS Final Guidance, Financial Relationships and Interest in Research with Human Subjects, 2003, available at <http://www.hhs.gov/ohrp/policy/index.html#topics> (last visited March 24, 2006); WeinfurtK.DinanM.AllsbrookJ.FriedmanJ.HallM.SchulmanK.SugarmanJ., “Policies of Academic Medical Centers for Disclosing Financial Conflicts of Interest to Potential Research Participants,”Academic Medicine81, no. 2 (2006): 113–118.
10.
La PumaJ.StockingC.RhoadesW.DarlingC.FernerR.NeubergerJ.VandenBurgM.DewsI.TobiasJ., “Financial Ties as Part of Informed Consent to Postmarketing Research: Attitudes of American Doctors and Patients,”British Medical Journal310 (1995): 1660–1663; KimS. Y.MillardR.NisbetP.CoxC.CaineE., “Potential Research Participants' Views Regarding Researcher and Institutional Financial Conflicts of Interest,”Journal of Medical Ethics30 (2004): 73–79.